HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Poster communications

Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

Kedra Joanna 1 Philippe Dieudé 2, 1 Hubert Marotte 3, 1 Alexandre Lafourcade 4, 1 Emilie Ducourau 1, 5 Thierry Schaeverbeke 6, 1 Aleth Perdriger 7, 1 Martin Soubrier 8, 1 Jacques Morel 9, 1 Arnaud Constantin 10, 1 Emmanuelle Dernis 11, 1 Valérie Royant 12, 1 Jean-Hugues Salmon 13, 1 Thao Pham 14, 1 Jacques-Eric Gottenberg 15, 1 Edouard Pertuiset 16, 1 Maxime Dougados 17, 1 Valérie Devauchelle-Pensec 18, 1 Philippe Gaudin 1, 19 Gregoire Cormier 20, 1 Philippe Goupille 21, 1 Xavier Mariette 22, 1 Francis Berenbaum 23, 1 Didier Alcaix 1 Sid Ahmed Rouidi 24, 1 Jean-Marie Berthelot 25, 1 Agnès Monnier 1 Christine Piroth 26, 1 Frederic Liote 27, 1 Vincent Goeb 28, 1 Cécile Gaujoux-Viala 1 Isabelle Chary Valckenaere 1 David Hajage 29, 1 Florence Tubach 30, 1 Bruno Fautrel 31, 1
Document type :
Poster communications
Complete list of metadata

https://hal.univ-brest.fr/hal-02158682
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Tuesday, June 18, 2019 - 11:39:27 AM
Last modification on : Wednesday, April 27, 2022 - 4:10:50 AM

Identifiers

  • HAL Id : hal-02158682, version 1

Citation

Kedra Joanna, Philippe Dieudé, Hubert Marotte, Alexandre Lafourcade, Emilie Ducourau, et al.. Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02158682⟩

Share

Metrics

Record views

126